Literature DB >> 21343900

Heart failure: acute ischemic events in HF--should we include sudden death?

John J V McMurray1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21343900     DOI： 10.1038/nrcardio.2011.22

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN： 1759-5002            Impact factor:   32.419


× No keyword cloud information.
  10 in total

1.  Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure.

Authors:  Gust H Bardy; Kerry L Lee; Daniel B Mark; Jeanne E Poole; Douglas L Packer; Robin Boineau; Michael Domanski; Charles Troutman; Jill Anderson; George Johnson; Steven E McNulty; Nancy Clapp-Channing; Linda D Davidson-Ray; Elizabeth S Fraulo; Daniel P Fishbein; Richard M Luceri; John H Ip
Journal:  N Engl J Med       Date:  2005-01-20       Impact factor: 91.245

2.  β-blockade with nebivolol for prevention of acute ischaemic events in elderly patients with heart failure.

Authors:  Giuseppe Ambrosio; Marcus D Flather; Michael Böhm; Alain Cohen-Solal; Adriano Murrone; Flavio Mascagni; Giulio Spinucci; Maria Giovanna Conti; Dirk J van Veldhuisen; Luigi Tavazzi; Andrew J S Coats
Journal:  Heart       Date:  2010-12-06       Impact factor: 5.994

3.  Effect of carvedilol on survival in severe chronic heart failure.

Authors:  M Packer; A J Coats; M B Fowler; H A Katus; H Krum; P Mohacsi; J L Rouleau; M Tendera; A Castaigne; E B Roecker; M K Schultz; D L DeMets
Journal:  N Engl J Med       Date:  2001-05-31       Impact factor: 91.245

4.  The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial.

Authors: 
Journal:  Lancet       Date:  1999-01-02       Impact factor: 79.321

5.  Rosuvastatin in older patients with systolic heart failure.

Authors:  John Kjekshus; Eduard Apetrei; Vivencio Barrios; Michael Böhm; John G F Cleland; Jan H Cornel; Peter Dunselman; Cândida Fonseca; Assen Goudev; Peer Grande; Lars Gullestad; Ake Hjalmarson; Jaromir Hradec; András Jánosi; Gabriel Kamenský; Michel Komajda; Jerzy Korewicki; Timo Kuusi; François Mach; Vyacheslav Mareev; John J V McMurray; Naresh Ranjith; Maria Schaufelberger; Johan Vanhaecke; Dirk J van Veldhuisen; Finn Waagstein; Hans Wedel; John Wikstrand
Journal:  N Engl J Med       Date:  2007-11-05       Impact factor: 91.245

6.  Determining the most appropriate components for a composite clinical trial outcome.

Authors:  M Angelyn Bethel; Rury Holman; Steven M Haffner; Robert M Califf; Alice Huntsman-Labed; Tsushung A Hua; John McMurray
Journal:  Am Heart J       Date:  2008-07-31       Impact factor: 4.749

7.  Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group.

Authors:  A Hjalmarson; S Goldstein; B Fagerberg; H Wedel; F Waagstein; J Kjekshus; J Wikstrand; D El Allaf; J Vítovec; J Aldershvile; M Halinen; R Dietz; K L Neuhaus; A Jánosi; G Thorgeirsson; P H Dunselman; L Gullestad; J Kuch; J Herlitz; P Rickenbacher; S Ball; S Gottlieb; P Deedwania
Journal:  JAMA       Date:  2000-03-08       Impact factor: 56.272

8.  Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction.

Authors: 
Journal:  N Engl J Med       Date:  1981-04-02       Impact factor: 91.245

9.  A randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality results.

Authors: 
Journal:  JAMA       Date:  1982-03-26       Impact factor: 56.272

10.  Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial.

Authors:  Luigi Tavazzi; Aldo P Maggioni; Roberto Marchioli; Simona Barlera; Maria Grazia Franzosi; Roberto Latini; Donata Lucci; Gian Luigi Nicolosi; Maurizio Porcu; Gianni Tognoni
Journal:  Lancet       Date:  2008-08-29       Impact factor: 79.321
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.